Label: SEI BELLA FLAWLESS LIQUID FOUNDATION 540 W- octinoxate 6% octisalate 5% titanium dioxide 2% lotion

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: OTC monograph not final

DISCLAIMER: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Drug Label Information

Updated January 11, 2023

If you are a consumer or patient please visit this version.

  • Active Ingredient

    Octinoxate 7.5%

  • Purpose

    Sunscreen

  • Use

    ■ helps prevent sunburn

  • Warnings

    For external use only

    Do not use on damaged or broken skin

  • WHEN USING

    When using this product keep out of eyes. Rinse with water to remove.

  • STOP USE

    Stop use and ask a doctor if rash occurs

  • Keep out of reach of children.

    If swallowed, get medical help or contact a Poison Control Center right away.

  • Directions

    ■ apply after cleanser, toner, and foundation primer. Blend outward with Sei Bella foundation brush or fingers.

    ■ apply liberally 15 minutes before sun exposure

    ■ use a water-resistant sunscreen if swimming or sweating

    ■ reapply at least every 2 hours

    ■ children under 6 months: ask a doctor

    Sun Protection Measures. Spending time in the sun increases you risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a broad-spectrum SPF value of 15 or higher and other sun protection measures including:

    ■ limit time in the sun, especially from 10 a.m.-2 p.m.

    ■ wear long-sleeve shirts, pants, hats, and sunglasses

    Other information

    ■ dermatologist and allergy tested

    ■ protect this product from excesssive heat and direct sun

  • Inactive ingredients

    isododecane, water, titanium oxide, dodecane, ethylhexyl palmitate, propanediol, polymethylsilsesquioxane, trimethylsiloxysilicate, peg-10 dimethicone, polysilicone-11, peg/ppg-18/18 dimethicone, dimethicone, barium sulfate, lecithin, glycerin, disteardimonium hectorite, magnesium aluminum silicate, phenoxyethanol, polysorbate 20, c18-36 acid triglyceride, caprylyl glycol, propylene carbonate, triethoxycaprylylsilane, calcium silicate, xanthum gum, cellulose gum, ouptnia ficus-indica stem extract, quartz, palmitoyl hexapeptide-19, may contain: iron oxide CI 77492, iron oxide 77491, iron oxide 77499

  • PRINCIPAL DISPLAY PANEL

    Box

  • INGREDIENTS AND APPEARANCE
    SEI BELLA FLAWLESS LIQUID FOUNDATION  540 W
    octinoxate 6% octisalate 5% titanium dioxide 2% lotion
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:54473-327
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    OCTISALATE (UNII: 4X49Y0596W) (OCTISALATE - UNII:4X49Y0596W) OCTISALATE1.5 g  in 30 mL
    OCTINOXATE (UNII: 4Y5P7MUD51) (OCTINOXATE - UNII:4Y5P7MUD51) OCTINOXATE1.8 g  in 30 mL
    TITANIUM DIOXIDE (UNII: 15FIX9V2JP) (TITANIUM DIOXIDE - UNII:15FIX9V2JP) TITANIUM DIOXIDE0.6 g  in 30 mL
    Inactive Ingredients
    Ingredient NameStrength
    FERRIC OXIDE YELLOW (UNII: EX438O2MRT)  
    POLYSORBATE 20 (UNII: 7T1F30V5YH)  
    TRIETHOXYCAPRYLYLSILANE (UNII: LDC331P08E)  
    ISODODECANE (UNII: A8289P68Y2)  
    PHENOXYETHANOL (UNII: HIE492ZZ3T)  
    C18-36 ACID TRIGLYCERIDE (UNII: ZRA72DR3R7)  
    CARBOXYMETHYLCELLULOSE SODIUM (UNII: K679OBS311)  
    OPUNTIA FICUS-INDICA STEM (UNII: MUD8892KHL)  
    SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
    WATER (UNII: 059QF0KO0R)  
    XANTHAN GUM (UNII: TTV12P4NEE)  
    CAPRYLYL GLYCOL (UNII: 00YIU5438U)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    LECITHIN, SOYBEAN (UNII: 1DI56QDM62)  
    POLYMETHYLSILSESQUIOXANE (4.5 MICRONS) (UNII: 59Z907ZB69)  
    DISTEARDIMONIUM HECTORITE (UNII: X687XDK09L)  
    MAGNESIUM ALUMINUM SILICATE (UNII: 6M3P64V0NC)  
    PROPYLENE CARBONATE (UNII: 8D08K3S51E)  
    CALCIUM SILICATE (UNII: S4255P4G5M)  
    PALMITOYL HEXAPEPTIDE-12 (UNII: HO4ZT5S86C)  
    FERRIC OXIDE RED (UNII: 1K09F3G675)  
    FERROSOFERRIC OXIDE (UNII: XM0M87F357)  
    DODECANE (UNII: 11A386X1QH)  
    ETHYLHEXYL PALMITATE (UNII: 2865993309)  
    PROPANEDIOL (UNII: 5965N8W85T)  
    TRIMETHYLSILOXYSILICATE (M/Q 0.66) (UNII: 5041RX63GN)  
    PEG-10 DIMETHICONE (600 CST) (UNII: 8PR7V1SVM0)  
    POLYSILICONE-15 (UNII: F8DRP5BB29)  
    PEG/PPG-18/18 DIMETHICONE (UNII: 9H0AO7T794)  
    DIMETHICONE (UNII: 92RU3N3Y1O)  
    BARIUM SULFATE (UNII: 25BB7EKE2E)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:54473-327-011 in 1 BOX06/01/2020
    130 mL in 1 BOTTLE, DISPENSING; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC monograph not finalpart35206/01/2020
    Labeler - Melaleuca Inc. (139760102)
    Registrant - Melaleuca Inc. (139760102)
    Establishment
    NameAddressID/FEIBusiness Operations
    Process Technologies & Packaging LLC.809172885manufacture(54473-327)